)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Tango Therapeutics
Tango Therapeutics (TNGX) investor relations material
Tango Therapeutics Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary12 Feb, 2026
Leadership transition and strategic vision
New CEO with long-standing board experience emphasizes continuity in strategy and priorities.
Focus remains on advancing vopimetostat toward regulatory approval, leveraging recent clinical proof of concept.
No drastic strategic changes expected following the leadership transition.
Leadership transition was a planned and collaborative process with the previous CEO and board.
Clinical development and trial updates
Pivotal trial protocol for vopimetostat in second-line pancreatic cancer developed, with strong FDA support and launch planned this year.
Ongoing 300-patient monotherapy study uses a hierarchical design focusing on PFS and overall survival, with rapid enrollment anticipated.
Combination trial with RAS inhibitors (daraxonrasib, zoldonrasib) recently started, showing early clinical activity and high enrollment interest.
Global trial design aims to mitigate regional changes in treatment paradigms and support robust recruitment.
Monotherapy data update and combination data are expected later this year.
Combination strategies and future opportunities
Preclinical synergy between vopimetostat and RAS inhibitors prompted rapid clinical development; 14 patients enrolled in daraxonrasib arm, 16 in zoldonrasib arm.
Selection of RP2D will be based on surpassing RAS inhibitor monotherapy benchmarks in second-line pancreatic cancer.
Duration of response and PFS are key factors in decision-making for combination regimens.
Plans to present combination study data this year, with next steps tied to data maturity and potential regulatory discussions.
No significant efficacy difference expected between the two RAS inhibitors; future strategy will depend on emerging data.
Vopimetostat combo: Path to registration?
RevMed RASi combo: How to differentiate strategies?
TNG456 vs Vopi: Lung cancer strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Tango Therapeutics earnings date
Q4 202527 Feb, 2026
Tango Therapeutics
Next Tango Therapeutics earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Tango Therapeutics Inc. is a biotechnology firm focused on the discovery and development of innovative treatments for cancer. The company's research is centered on creating drugs that target specific genetic vulnerabilities in cancer cells. One of its leading projects, TNG908, is a synthetic lethal small molecule inhibitor designed for treating cancers characterized by methylthioadenosine phosphorylase deletions. Additionally, Tango Therapeutics is developing several other compounds, including TNG462 for similar indications, TNG260 targeting repressor element-1 silencing transcription, TNG348 aimed at BRCA1 or BRCA2-mutant cancers, and another compound targeting STK11-mutant cancers. The company is based in Boston, Massachusetts and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage